Skip to main content
. 2021 Sep 29;20:100157. doi: 10.1016/j.mcpro.2021.100157

Table 3.

Rate of change in CSF protein levels caused by delays in sample processing in cell-free and whole CSF of patients with or suspected of neurological disorders

Protein CV
RCF (%) SECF PCF RWH (%) SEWH PWH
Intra/inter
CTSH 5/11 56.91 3.38 0.00107 15.16 5.25 0.0666
ENTPD5 9/11 −6.48 0.38 0.0053 −4.3 0.45 0.0135
WWP2∗ 6/15 − 6.93 0.45 0.0066 −3.19 0.63 0.0436
CDHR5∗ 5/10 6.56 0.74 0.00933 −0.28 1.3 0.805
CHRDL2∗ 6/10 1.76 0.18 0.00974 −0.03 0.47 0.937
TYMP 9/13 5.81 1.14 0.0285 −1.65 1.65 0.415
DDC 5/12 −2.95 0.53 0.0343 −1.67 0.48 0.078
NPTXR 6/12 1.46 0.3 0.0369 0.28 0.5 0.652
APEX1∗ 6/14 5.33 1.24 0.0433 −4.11 1.31 0.106
CD2AP 6/8 −1.57 0.72 0.169 −2.43 0.26 0.0129
ADA 5/29 −1.08 1.09 0.422 −1 0.14 0.0205
RNASE3 6/18 −1.4 1.81 0.474 −2.36 0.39 0.03
NPM1∗ 4/16 7.13 7.31 0.541 −14.79 0.51 0.00561

Rates of change (R, %) in protein levels per hour of delay in sample processing as determined by the comparison of samples with baseline (<1 h) and 6 h delay at room temperature (22 °C) are given for both cell-free (CF) and whole (WH) CSF. Only proteins with a significant change (p < 0.05) within 6 h as determined by standard Student's t test are listed. The relative variability in inter/intra runs along with the rate of change for additional proteins, which are provided in supplemental Table S3. Highlighted proteins (∗) showed changes in detectable presence between the two sampled time points; therefore, rate is an approximation.

Abbreviations: ADA, adenosine deaminase; APEX1, DNA-(apurinic or apyrimidinic site) lyase; CD2AP, CD2-associated protein; CDHR5, cadherin-related family member 3; CHRDL2, chordin-like 2; CTSH, cathepsin H; DDC, aromatic-l-amino-acid decarboxylase; ENTPD5, ectonucleoside triphosphate diphosphohydrolase 5; NPM1, nucleophosmin 1; NPTXR, neuronal pentraxin receptor; RNASE3, ribonuclease, RNase A family, 3; TYMP, thymidine phosphorylase; WWP2, WW domain containing E3 ubiquitin protein ligase 2.